Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin

Journal of General Virology

Volumn 84, Issue 2, 2003, Pages 353-360

  Hart, Melanie L ^a   Saifuddin, Mohammed ^a   Spear, Gregory T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; 1 DEOXYNOJIRIMYCIN DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; CASTANOSPERMINE; EPITOPE; GLYCOPROTEIN GP 120; LECTIN; MANNOSE; MANNOSE BINDING PROTEIN; MANNOSIDASE INHIBITOR; MONOCLONAL ANTIBODY; N ACETYL BETA GLUCOSAMINIDASE; SIALIC ACID; SIALIDASE INHIBITOR; SWAINSONINE;

ANTIGEN FUNCTION; ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DISEASE DURATION; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG EFFICACY; ENDOPLASMIC RETICULUM; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IC 50; IMMUNE SYSTEM; IMMUNOREACTIVITY; LEUKOPENIA; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; VIROGENESIS; VIRUS CULTURE; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

1-DEOXYNOJIRIMYCIN; BINDING SITES; CELL LINE; ENZYME INHIBITORS; GLUCOSIDASES; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; INDOLIZINES; MANNOSE-BINDING LECTIN; MANNOSIDASES; NEURAMINIDASE; NEUTRALIZATION TESTS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037311412     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18734-0     Document Type: Review

References (37)

1. Back, N. K., Smit, L., De Jong, J. J., Keulen, W., Schutten, M., Goudsmit, J. & Tersmette, M. (1994). An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199, 431-438.
2. Baptista, J. A., Goss, P., Nghiem, M., Krepinsky, J. J., Baker, M. & Dennis, J. W. (1994). Measuring swainsonine in serum of cancer patients: phase I clinical trial. Clin Chem 40, 426-430.
3. Barbas, C. F., III Bjorling, E., Chiodi, F. & 8 others. (1992). Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A 89, 9339-9343.
4. Block, T. M., Lu, X., Mehta, A. S. & 7 other authors (1998). Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat Med 4, 610-614.
5. Childs, R. A., Drickamer, K., Kawasaki, T., Thiel, S., Mizuochi, T. & Feizi, T. (1989). Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man. Biochem J 262, 131-138.
6. Dedera, D., Vander Hayden, N. & Ratner, L. (1990). Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing. AIDS Res Hum Retrov 6, 785-794.
7. Ezekowitz, R. A., Kuhlman, M., Groopman, J. E. & Byrn, R. A. (1989). A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 169, 185-196.
8. Gruters, R. A., Neefjes, J. J., Tersmette, M., de Goede, R. E., Tulp, A., Huisman, H. G., Miedema, F. & Ploegh, H. L. (1987). Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature 330, 74-77.
9. Haurum, J. S., Thiel, S., Jones, I. M., Fischer, P. B., Laursen, S. B. & Jensenius, J. C. (1993). Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7, 1307-1313.
10. Jack, D. L., Klein, N. J. & Turner, M. W. (2001). Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 180, 86-99.
11. Jacob, G. S. (1995). Glycosylation inhibitors in biology and medicine. Curr Opin Struct Biol 5, 605-611.
12. Karpas, A., Fleet, G. W., Dwek, R. A., Petursson, S., Namgoong, S. K., Ramsden, N. G., Jacob, G. S. & Rademacher, T. W. (1988). Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proc Natl Acad Sci U S A 85, 9229-9233.
13. Kawasaki, N., Kawasaki, T. & Yamashina, I. (1983). Isolation and characterization of a mannan-binding protein from human serum. J Biochem 94, 937-947.
14. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N. & Gregory, T. J. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265, 10373-10382.
15. Ma, Y., Shida, H. & Kawasaki, T. (1997). Functional expression of human mannan-binding proteins (MBPs) in human hepatoma cell lines infected by recombinant vaccinia virus: post-translational modification, molecular assembly, and differentiation of serum and liver MBP. J Biochem 122, 810-818.
16. Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A. & Sim, R. B. (1995). Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1, 237-243.
17. Means, R. E. & Desrosiers, R. C. (2000). Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J Virol 74, 11181-11190.
18. Mehta, A., Zitzmann, N., Rudd, P. M., Block, T. M. & Dwek, R. A. (1998). Alpha-glucosidase inhibitors as potential broad based antiviral agents. FEBS Lett 430, 17-22.
19. Montefiori, D. C., Robinson, W. E., Jr. & Mitchell, W. M. (1988). Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 85, 9248-9252.
20. Moore, J. P., Wallace, L. A., Follett, E. A. & McKeating, J. A. (1989). An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS 3, 155-163.
21. Moore, J. P., Sattentau, Q. J., Wyatt, R. & Sodroski, J. (1994). Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol 68, 469-484.
22. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F. & Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67, 6642-6647.
23. Neth, O., Jack, D. L., Dodds, A. W., Holzel, H., Klein, N. J. & Turner, M. W. (2000). Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68, 688-693.
24. Ohtani, K., Suzuki, Y., Eda, S. & 7 other authors (1999). High-level and effective production of human mannan-binding lectin (MBL) in Chinese hamster ovary (CHO) cells. J Immunol Methods 222, 135-144.
25. Petersen, S. V., Thiel, S. & Jensenius, J. C. (2001). The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38, 133-149.
26. Purtscher, M., Trkola, A., Gruber, G., Buchacher, A., Predl, R., Steindl, F., Tauer, C., Berger, R., Barrett, N., Jungbauer, A. and others (1994). A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 10, 1651-1658.
27. Saifuddin, M., Hart, M. L., Gewurz, H., Zhang, Y. & Spear, G. T. (2000). Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 81, 949-955.
28. Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D. & Moore, J. P. (2002). The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 76, 7293-7305.
29. Scanlan, C. N., Pantophlet, R., Wormald, M. R. & 7 other authors (2002). The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120. J Virol 76, 7306-7321.
30. Sears, P. & Wong, C. H. (1998). Enzyme action in glycoprotein synthesis. Cell Mol Life Sci 54, 223-252.
31. Takefman, D. M., Sullivan, B. L., Sha, B. E. & Spear, G. T. (1998). Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis. Virology 246, 370-378.
32. Tierney, M., Pottage, J., Kessler, H. & other authors (1995). The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and infectious Diseases. J Acquir Immune Defic Syndr Hum Retrovirol 10, 549-553.
33. Trkola, A., Purtscher, M., Muster, T. & 7 other authors (1996). Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 70, 1100-1108.
34. van Emmerik, L. C., Kuijper, E. J., Fijen, C. A., Dankert, J. & Thiel, S. (1994). Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol 97, 411-416.
35. Walker, B. D., Kowalski, M., Goh, W. C., Kozarsky, K., Krieger, M., Rosen, C., Rohrschneider, L., Haseltine, W. A. & Sodroski, J. (1987). Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc Natl Acad Sci U S A 84, 8120-8124.
36. Weis, W. I., Taylor, M. E. & Drickamer, K. (1998). The C-type lectin superfamily in the immune system. Immunol Rev 163, 19-34.
37. Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A. & Sodroski, J. G. (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393,